Favorable Press Coverage Somewhat Unlikely to Impact LHC Group (LHCG) Stock Price
News headlines about LHC Group (NASDAQ:LHCG) have been trending positive on Saturday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LHC Group earned a daily sentiment score of 0.34 on Accern’s scale. Accern also gave media coverage about the health services provider an impact score of 47.2318447439134 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the headlines that may have impacted Accern’s analysis:
- LHC Group, Inc. (LHCG) Expected to Announce Quarterly Sales of $283.31 Million (americanbankingnews.com)
- Brokerages Anticipate LHC Group, Inc. (LHCG) Will Post Earnings of $0.62 Per Share (americanbankingnews.com)
- Research Report Identifies Flotek Industries, SuperValu, NextEra Energy, Acadia Healthcare, LHC Group, and Alnylam Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement (finance.yahoo.com)
- MD2U sells for $4 million to another local company (bizjournals.com)
Several brokerages recently issued reports on LHCG. SunTrust Banks reissued a “buy” rating and set a $75.00 target price on shares of LHC Group in a research note on Friday, November 3rd. Oppenheimer upped their price objective on shares of LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Craig Hallum restated a “buy” rating and set a $80.00 price objective (up previously from $67.00) on shares of LHC Group in a report on Tuesday, November 7th. Royal Bank of Canada upped their price objective on shares of LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Finally, Jefferies Group upped their price objective on shares of LHC Group from $68.00 to $83.00 and gave the stock a “buy” rating in a report on Tuesday, November 7th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, three have given a hold rating and nine have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $77.10.
TRADEMARK VIOLATION WARNING: “Favorable Press Coverage Somewhat Unlikely to Impact LHC Group (LHCG) Stock Price” was reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.dailypolitical.com/2018/02/10/favorable-press-coverage-somewhat-unlikely-to-impact-lhc-group-lhcg-stock-price.html.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.